Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-317248
Filing Date
2025-12-12
Accepted
2025-12-12 12:26:20
Documents
7
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 6-K d593009d6k.htm 6-K 8483
2 EX-99.1 d593009dex991.htm EX-99.1 12686
3 EX-99.2 d593009dex992.htm EX-99.2 28257
4 GRAPHIC g593009g09n62.jpg GRAPHIC 3252
5 GRAPHIC g593009g1212015655717.jpg GRAPHIC 2601
6 GRAPHIC g593009g1212015809638.jpg GRAPHIC 2601
7 GRAPHIC g593009g76a60.jpg GRAPHIC 3183
  Complete submission text file 0001193125-25-317248.txt   65975
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251567230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)